Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

This observational study is watching how a new inserter device works when placing a tiny travoprost implant into the eye. Travoprost is a medication that lowers eye pressure in people with open-angle glaucoma — a condition where increased pressure in the eye can slowly damage vision. The study is observational, meaning researchers are recording real-world outcomes rather than testing a brand-new treatment. **You may be eligible if...** - You have been diagnosed with open-angle glaucoma - You are 18 years of age or older and your doctor has recommended this eye implant as part of your care **You may NOT be eligible if...** - You are pregnant or breastfeeding - Your doctor determines the procedure is not appropriate for your current eye health Talk to your doctor to see if this trial is right for you.